<DOC>
	<DOCNO>NCT00679705</DOCNO>
	<brief_summary>This trial consist two part : A pilot study three-way cross trial determine high well tolerate dose Ritodrine ( Pre-Par® ) , impact Atosiban ( Tractocile® ) hemodynamics hence design final study . The final study plan three-way crossover trial investigate compare cardiovascular effect Ritodrine , Atosiban placebo relate effect pharmacokinetics Ritodrine Atosiban ( PK/PD model ) .</brief_summary>
	<brief_title>Influence Tocolytical Medications Hemodynamics ( Central Peripheral ) Vascular Function Pilot Study Determine Design Final Study Final Study Itself</brief_title>
	<detailed_description />
	<mesh_term>Atosiban</mesh_term>
	<mesh_term>Ritodrine</mesh_term>
	<mesh_term>Vasotocin</mesh_term>
	<criteria>Age 20 40 year old ; In good health , especially cardiovascular disease , obstructive lung disease , chronic kidney disease diabetes mellitus . Using proper anticonception method ( orally , subcutaneously ) ; A negative pregnancy test . Intolerance Ritodrine ; On chronic medication , except oral subcutaneous contraception History present presentation cardiac arrythmias ; Risk pregnant less 6 month postpartum ; Giving breastfeeding ; Previous uteral surgery ; Using intrauteral device ( IUD ) ; A severe addiction : nicotine ( &gt; 10 cigarettes/day ) , alcohol ( &gt; 3 units/day ) , caffeine ( &gt; 5 units/day ) extralegally drug .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Hemodynamics arterial function healthy female</keyword>
</DOC>